Highlights and Quick Summary
- Shareholders Equity and Liabilities (Total) for the quarter ending February 28, 2023 was $409 Million (a -3.9% decrease compared to previous quarter)
- Year-over-year quarterly Shareholders Equity and Liabilities (Total) decreased by -10.98%
- Annual Shareholders Equity and Liabilities (Total) for 2022 was $454 Million (a 3.84% increase from previous year)
- Annual Shareholders Equity and Liabilities (Total) for 2021 was $437 Million (a 34.99% increase from previous year)
- Annual Shareholders Equity and Liabilities (Total) for 2020 was $324 Million (a 0.14% increase from previous year)
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Shareholders Equity and Liabilities (Total) of Organigram Holdings Inc.
Most recent Shareholders Equity and Liabilities (Total)of OGI including historical data for past 10 years.Interactive Chart of Shareholders Equity and Liabilities (Total) of Organigram Holdings Inc.
Organigram Holdings Inc. Shareholders Equity and Liabilities (Total) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $408.84 | – | – | – | – |
| 2022 | $425.45 | $453.72 | $459.27 | $460.18 | $453.72 |
| 2021 | $434.17 | $436.95 | $460.1 | $308.16 | $436.95 |
| 2020 | $359.53 | $323.69 | $310.34 | $381.28 | $323.69 |
| 2019 | $355.12 | $323.24 | $319.28 | $282.3 | $323.24 |
| 2018 | $281.78 | $236.94 | – | – | $236.94 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic